New publication highlights A1M protein’s role in regulating free hemoglobin
Scientists associated with A1M Pharma have published a scientific article that deepens the understanding of how free hemoglobin affects the function of the heart and the possibility to neutralize these effects with A1M, a protein that occurs naturally in the human body. The article was published on September 25 in the scientific journal Free Radical Biology and Medicine.This is the English version of a press release that was originally published in Swedish on October 7 2015, at 08:34 a.m. A1M Pharma is developing treatments for pre-eclampsia and acute kidney injury, two indications where